Free tool
Upcoming earnings calendar
See who reports in the next 30, 60 or 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
See who reports in the next 30, 60 or 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
See who reports in Europe in the next 60 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
7 companies reporting in the next 60 days. Clear filters
Data as of Aug 27, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Theme | Market cap (USD) | 1M return | |
|---|---|---|---|---|---|
| Monday, Sep 21 · in 25 days · 2 companies | |||||
| ABVX.PA | ABIVAX Société Anonyme | Rare disease | $10.21B | −5.63% | |
| 2X1.DE | ABIVAX Société Anonyme | Rare disease | — | −6.77% | |
| Thursday, Sep 24 · in 28 days · 1 company | |||||
| 0AB6.L | Hyloris Pharmaceuticals SA | Rare disease | $185.32M | −1.79% | |
| Tuesday, Sep 29 · in 33 days · 2 companies | |||||
| GNFT.PA | Genfit S.A. | Rare disease | $830.56M | ||
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock. Looking for a name that isn't listed? Jump straight to it:
| +5.30% |
| XUP.DE | Genfit S.A. | Rare disease | $258.22M | −1.81% |
| Thursday, Oct 22 · in 56 days · 1 company | |||||
| 1AE.DE | argenx SE | Rare disease | — | +15.89% | |
| Monday, Oct 26 · in 60 days · 1 company | |||||
| 0HNC.L | BioMarin Pharmaceutical Inc. | Rare disease | $9.93B | +0.05% | |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India). Reporting dates are public estimates and can shift.